Biomarkers for ovarian cancer CTAP3-related proteins
US11255857B2 · kind B2 · utility
0Cited by
3References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 10, 2017 |
| Grant date | Feb 22, 2022 |
| Priority date | — |
| Expiry date | Jan 23, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides a protein-based biomarker that is useful in qualifying ovarian cancer status in a patient. In particular, the biomarker of this invention is useful to classify a subject sample as ovarian cancer or non-ovarian cancer. The biomarker can be detected by SELDI mass spectrometry.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.